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Abstract
Cadmium (Cd) has been in industrial use for a long period of time. Its serious toxicity moved into
scientific focus during the middle of the last century. In this review, we discuss historic and recent
developments of toxicological and epidemiological questions, including exposition sources,
resorption pathways and organ damage processes.
Background
Cadmium (group IIB of the periodic table of elements) is
a heavy metal posing severe risks to human health. Up to
this day, it could not be shown that cadmium has any
physiological function within the human body. Interest
has therefore risen in its biohazardous potential. As first
described by Friedrich Stromeyer (Göttingen, Germany)
in 1817, cadmium intoxication can lead to kidney, bone,
and pulmonary damages.
In this article, we review recent developments and find-
ings of cadmium toxicology.
Occurrence
Cadmium is regularly found in ores together with zinc,
copper and lead. Therefore volcanic activity is one natural
reason for a temporary increase in environmental cad-
mium concentrations. Cadmium is widely used in indus-
trial processes, e.g.: as an anticorrosive agent, as a
stabilizer in PVC products, as a colour pigment, a neutron-
absorber in nuclear power plants, and in the fabrication of
nickel-cadmium batteries. Phosphate fertilizers also show
a big cadmium load. Although some cadmium-contain-
ing products can be recycled, a large share of the general
cadmium pollution is caused by dumping and incinerat-
ing cadmium-polluted waste [1]. In Scandinavia for exam-
ple, cadmium concentration in agricultural soil increases
by 0.2% per year. Total global emission of cadmium
amounts to 7000 t/year [2].
Resorption into human body
The maximum permissible value for workers according to
German law is 15 μg/l. For comparison: Non-smokers
show an average cadmium blood concentration of 0.5 μg/
l.
Basically there are three possible ways of cadmium resorp-
tion: Gastrointestinal, pulmonary and dermal.
Published: 10 September 2006
Journal of Occupational Medicine and Toxicology 2006, 1:22 doi:10.1186/1745-6673-1-22
Received: 28 September 2005
Accepted: 10 September 2006
This article is available from: http://www.occup-med.com/content/1/1/22
© 2006 Godt et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Occupational Medicine and Toxicology 2006, 1:22 http://www.occup-med.com/content/1/1/22
Page 2 of 6
(page number not for citation purposes)
Digestive system
The uptake through the human gastrointestinal is approx-
imately 5% of an ingested amount of cadmium, depend-
ing on the exact dose and nutritional composition [3]. An
average German citizen has a daily intake of 30–35 μg
cadmium; 95% of this taken up with food and drinks. An
average smoker has an additional intake of 30 μg per day
[4]. Several factors can increase this amount, such as low
intakes of vitamin D, calcium, and trace elements like zinc
and copper.
Concerning zinc and calcium, it is assumed that their
molecular homology could be a reason for a compensa-
tory higher cadmium resorption [5]. Foulkes was able to
show such a competitive resorption of Cd in an animal
model: In rat jejunum, the cadmium uptake was
depressed by relatively high concentrations of other poly-
valent cations, including Pb, Ni, Cr3+, Sr, and Mg [6].
Furthermore a high fiber diet increases the dietary cad-
mium intake [7]. The most important metabolic parame-
ter for cadmium uptake is a person's possible lack of iron.
People with low iron supplies showed a 6% higher uptake
of cadmium than those with a balanced iron stock [8].
This is the main reason for the higher cadmium resorption
in people with anaemia and habitual iron deficit, such as
children or menstruating women. Low iron blood levels
stimulate the expression of DCT-1, a metal ion transporter
in the GI tract, serving as a gate for cadmium resorption
[9].
Respiratory system
The major source of inhalative cadmium intoxication is
cigarette smoke. The human lung resorbes 40–60% of the
cadmium in tobacco smoke [10]. A 50 year-old average
non-smoker has a cadmium body burden of 15 mg. While
a comparable life-long smoker shows a value of 30 mg.
Smokers generally have cadmium blood levels 4–5 times
those of non-smokers [7].
Workers exposed to cadmium-containing fumes have
been reported to develop acute respiratory distress syn-
dromes (ARDS) [11].
Inhalativly resorbed cadmium reaches blood circulation
usually in form of cadmium-cysteine complexes [12].
Dermal resorption
Little research has been done on dermal absorption of
cadmium. In 1991, Wester et al. experimented on the
resorption from cadmium-contaminated soil and water
solutions by human cadaver skin in a diffusion cell-
model. They could demonstrate a penetration of 8.8 %
(soil) and 12.7% (water) of the applied cadmium dose
into the skin; while the plasma uptake from soil was
0.01% and 0.07% from water [13]. Lansdown and Samp-
son administered a cadmium chloride solution to the dor-
sum of rats (shaved skin) daily for 10 days. The skin
showed hyperkeratosis and acanthosis with occasional
ulcerative change, and an increase of the mitotic index of
the skin cells. Also cadmium concentration in blood, liver
and kidney increased, thus indicating percutaneous
absorption [14].
Two mechanisms facilitate cadmium absorption by the
skin: binding of a free cadmium ion to sulfhydryl radicals
of cysteine in epidermal keratins, or an induction and
complexing with metallothionein [15].
Handling Of cadmium in the body
Once taken up by the blood, the majority of cadmium is
transported bound to proteins, such as Albumin and Met-
allothionein.
The first organ reached after uptake into the GI-blood is
the liver. Here cadmium induces the production of Metal-
lothionein. After consecutive hepatocyte necrosis and
apoptosis, Cd-Metallothionein complexes are washed
into sinusoidal blood. From here, parts of the absorbed
cadmium enter the entero-hepatical cycle via secretion
into the biliary tract in form of Cadmium-Glutathione
conjugates. Enzymatically degraded to cadmium-cysteine
complexes in the biliary tree, cadmium re-enters the small
intestines [12].
The main organ for long-term cadmium accumulation is
the kidney [16]. Here the half-life period for cadmium is
approx. 10 years. A life-long intake can therefore lead to a
cadmium accumulation in the kidney, consequently
resulting in tubulus cell necrosis.
The blood concentration of cadmium serves as a reliable
indicator for a recent exposition, while the urinary con-
centration reflects past exposure, body burden and renal
accumulation [3]. Excretion of Cadmium takes place via
faeces and urine. Figure 1 gives a scheme on the handling
of Cadmium in human body.
Hazards to human health
Acute intoxication
The respiratory system is affected severely by the inhala-
tion of cadmium-contaminated air: Shortness of breath,
lung edema and destruction of mucous membranes as
part of cadmium-induced pneumonitis are described
[17]. As already reported in 1942, intake of cadmium-con-
taminated food causes acute gastrointestinal effects, such
as vomiting and diarrhoea [18].Journal of Occupational Medicine and Toxicology 2006, 1:22 http://www.occup-med.com/content/1/1/22
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Kidney damage
Kidney damage has long since been described to be the
main problem for patients chronically exposed to cad-
mium [19]. As mentioned above, cadmium reaches the
kidney in form of cadmium-metallothionein (Cd-MT).
Cd-MT is filtrated in the glomerulus, and subsequently
reabsorbed in the proximal tubulus. It then remains in the
tubulus cells and makes up for the major part of the cad-
mium body burden. The amount of cadmium in the kid-
ney tubulus cells increases during every person's life span.
A perturbance of the phosphor and calcium metabolism
as a result of this phenomenon is in discussion [20]. An
increasing cadmium load in the kidney is also discussed to
result in a higher calcium excretion, thus leading to a
higher risk of kidney stones.
The urinary cadmium excretion was shown to correlate
with the degree of cadmium induced kidney damage: A
urinary excretion of 2.5 micrograms cadmium per gram
creatinine reflects a renal tubular damage degree of 4%
[7]. The primary markers of kidney damage however, are
the urinarily excreted β2-microglobulin, N-acetyl-α-D-
glucosaminidase (NAG), and retinol-binding-protein
(RBP) [21]. The ChinaCad-Study showed significantly
higher values for urinary β2-Microglobulin and RBP in
people with high blood cadmium concentration than in
people with normal values [3]. In the first group, both
glomerular and tubular damages where observed. It has
been discussed whether or not tubular damage is reversi-
ble [22]. The general opinion today however is, that it's
irreversible.
Effects of cadmium in reproductive biology
Cadmium appears to interfere with the ovarian steroidog-
enic pathway in rats. Piasek et al. evaluated the direct
effects of in vitro cadmium exposure on steroidogenesis in
rat ovaries.
The most affected were productions of progesterone and
testosterone [23]. Low dosages of cadmium are reported
to stimulate ovarian progesterone biosynthesis, while
high dosages inhibit it [24]. Maternal exposure to cad-
mium is associated with low birth wight and an increase
of spontaneous abortion [25,26]. Some evidence exists
also that cadmium is a potent nonsteroidal estrogen in
vivo and in vitro. Studies in rats showed that cadmium
precipitates enhanced mammary development and
increased uterine wight [27].
Handling of cadmium in human body Figure 1
Handling of cadmium in human body. Figure legend text: Metabolism, storage and excretion of cadmium in human body. 
Modified after [12].
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Bone damage and the Itai-Itai-disease
Several studies in the 20th Century showed a connection
between cadmium intoxication and bone damage, e.g. in
workers exposed to cadmium-polluted fume and dust
[28].
Cadmium could also be shown to be associated with
occurrences of Itai-Itai, a disease under witch patients
show a wide range of symptoms such as: low grade of
bone mineralization, high rate of fractures, increased rate
of osteoporosis, and intense bone associated pain. An epi-
demic occurrence of the Itai-Itai disease was observed in
the Jinzu river basin (Japan) in the 1940s. In a study on
this occasion, patients where found to show the character-
istic symptoms after having eaten rice, grown on fields
irrigated with highly cadmium polluted water. Also
pseudo fractures characteristic of osteomalacia and severe
skeletal decalcification could be observed. Criticism of
this study came up because of the fact that the majority of
the patient collective was made up of women in the post-
menopause [29]. Underlying osteoporosis, possibly
enhanced by cadmium intoxication, was suggested to be
the actual reason for the observed symptoms [30].
Further evidence for the causality of cadmium intoxica-
tion for bone maladies was found in 2003 by Honda et al.
They could describe an inverse correlation of the STIFF
index (an ultrasound method for measuring bone den-
sity) and urine cadmium concentration [25]. Similar find-
ings where made within the OSCAR-Study, conducted
with 1021 people from southern Sweden. Here a signifi-
cant negative correlation could be shown between urine
cadmium concentration and low bone mineral density;
especially in people of an age of 60 years and above. Fur-
thermore evidence for an increased risk of forearm frac-
tures in cadmium-exposed individuals was found [31].
Individuals included in this study were either battery
plant workers, or inhabitants of a town close to the battery
plant. A collective of unexposed people where included as
reference group.
The Belgian CadmiBel study – conducted between 1985
and 1989 – came to similar conclusions: Even minimal
environmental exposure to cadmium is supposed to cause
skeletal demineralisation [32]. Some of the CadmiBel-
participants were later tested for forearm bone density
during the so called PheeCad Study (1992–1995). Here
too lower bone densities where found in individuals pre-
viously exposed to cadmium. The most interesting aspect
of this study was the fact, that their total cadmium body
burden (according to the urinary cadmium excretion) was
significantly lower than that of Japanese Itai-Itai patients:
CadmiBel/PheeCad participants showed a urinary cad-
mium excretion of only 1 μg/g creatinine, while Itai-Itai
patients where found to have an excretion of approxi-
mately 30 μg/g creatinine.
The exact mechanism of interference between cadmium
and bone mineralization remains to be discovered. Pres-
ently, a direct influence on osteoblast and osteoclast func-
tion seems as likely as an indirect influence via induction
of renal dysfunction [33]. A perturbance of the vitamin
D3 metabolic pathway through cadmium is also in dis-
cussion: According to these hypothesises, lead and cad-
mium interact with renal mitochondrial hydroxylases of
the vitamin D3 endocrine complex [34]. Figure 2 gives an
overview on the effects of cadmium in several organ sys-
tems.
Carcinogenity
There is some proof that cadmium can cause cancer.
Waalkes et al. have shown that a subcutaneous injection
of cadmium chloride can induce prostate cancer in Wistar
rats [35]. This group also postulated that high doses of
cadmium can cause severe testicular necrosis in rats, fol-
lowed by a higher incidence of testicular interstitial
tumors. In contrast to laboratory data though, epidemio-
logical studies could not convincingly prove cadmium to
be a cause of prostate cancer [36].
Early publications however suggested an association of
cadmium and renal cancer in humans [37]. This assump-
tion was confirmed in 2005 by a systematic review of
seven epidemiological and eleven clinical studies [38].
Consequently, the IARC (International Agency for
Research on Cancer) decided to classify cadmium as a
human carcinogen group I. Latest data however supports
the assumption that only an uptake of cadmium via the
respiratory system has carcinogenic potential [3].
Effects of cadmium on several organ systems Figure 2
Effects of cadmium on several organ systems.
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Although molecular mechanisms of cadmium-induced
carcinogenesis are not yet understood, several factors may
contribute to it: Up-regulation of mitogenic signalling,
perturbance of DNA-repairing mechanism, and acquisi-
tion of apoptotic resistance by cadmium exposure [39]. A
substitution of zinc by cadmium in transcription-regulat-
ing proteins is also in discussion. Furthermore, new data
showed that cadmium is able to change the conformation
of E-Cadherin, a transmembrane Ca(II)-binding glyco-
protein. E-Cadherin plays an important role in cell-cell
adhesions, especially in epidermal cells [40]. These results
are consistent with the hypothesis that E-cadherin may be
a direct molecular target for Cd(2+) toxicity.
There are many further fields of occupational medicine
and toxicology in which cadmium is currently suspected
to play a major role [41-45] They are omitted with regard
to the limited space and the comprehensiveness of this
review.
Conclusion
Latest studies have proven the importance of a reduction
of cadmium emissions for human health. Some efforts in
this direction have been made, especially within in the
European Union. Cadmium, on the one hand, is example
for an industrially used substance with negative long-time
effects on human health. On the other hand, it is an exam-
ple for the beneficial potential of the international coop-
eration of laboratories, universities and local authorities.
Efforts to research and reduce the effects of cadmium
emissions have to continue. A number of promising
projects give rise to the hope that, in the future, alternative
testing methods may allow a reduction of the number of
laboratory animals necessary for this research.
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